Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

NACompletedINTERVENTIONAL
Enrollment

5,000

Participants

Timeline

Start Date

September 30, 1998

Study Completion Date

September 30, 2005

Conditions
Bipolar Disorder
Interventions
DRUG

lithium

DRUG

valproate

DRUG

bupropion

DRUG

paroxetine

DRUG

lamotrigine

DRUG

risperidone

DRUG

inositol

DRUG

tranylcypromine

BEHAVIORAL

Cognitive Behavioral Therapy

BEHAVIORAL

Family-focused Therapy

BEHAVIORAL

Interpersonal and Social Rhythms Therapy

Trial Locations (11)

15213

University of Pittsburgh, Pittsburgh

44106

Case Western Reserve University, Cleveland

74135

University of Oklahoma Health Sciences Center, Tulsa

77030

Baylor College of Medicine, Houston

80220

University of Colorado, Colorado Psychiatric Health Clinical Investigation Center, Denver

97201

Portland Veteran's Administration Medical Center, Portland

94305-5723

Stanford University School of Medicine, Stanford

02114

Massachusetts General Hospital, Boston

01655

University of Massachusetts Medical Center, Worcester

19104-2649

University of Pennsylvania Medical Center, Philadelphia

78229-3900

University of Texas Health Science Center at San Antonio, San Antonio

All Listed Sponsors
lead

National Institute of Mental Health (NIMH)

NIH

NCT00012558 - Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) | Biotech Hunter | Biotech Hunter